Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis
Open Access
- 1 July 1991
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 34 (7) , 815-821
- https://doi.org/10.1002/art.1780340706
Abstract
Increased serum levels of hyaluronate (HA) have been found in patients with rheumatoid arthritis (RA). This probably reflects increased leakage of HA from the inflamed joints into the circulation. In a prospective study of 40 patients with early RA, we evaluated the relationship of serum HA to clinical, laboratory, and radiologic parameters of disease activity. The patients were followed for 12 months; all had active disease at study entry. We confirmed the previous finding of higher serum HA concentrations in RA patients compared with healthy controls. At study entry, the patients' serum HA levels correlated positively with clinical and laboratory parameters of acute inflammation. Despite marked clinical improvement during therapy with second-line drugs, the serum HA levels increased during the followup period. At the end of 1 year, these levels correlated with the radiologic progression of joint lesions, whereas they showed a less pronounced correlation with clinical or laboratory parameters of inflammation. We conclude that, in early RA, serum HA levels may reflect ongoing joint destruction and may even predict subsequent joint damage.Keywords
This publication has 27 references indexed in Scilit:
- Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the Blood Markers Hyaluronic Acid, Orosomucoid, and Keratan SulfateArthritis & Rheumatism, 1990
- Determination of synovial fluid hyaluronate concentration and polymerisation by high performance liquid chromatography.Annals of the Rheumatic Diseases, 1989
- CHANGES IN THE VISCOSITY OF HYALURONIC ACID AFTER EXPOSURE TO A MYELOPEROXIDASE‐DERIVED OXIDANTArthritis & Rheumatism, 1989
- Proceedings from the Annual Meeting of the Finnish Society for Rheumatology. Heinola, 9-10 February 1989Scandinavian Journal of Rheumatology, 1989
- Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor α, tumor necrosis factor β (lymphotoxin), interleukin‐1α, and interleukin‐1βArthritis & Rheumatism, 1988
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.Annals of the Rheumatic Diseases, 1988
- Hand Radiography of 200 Patients with Rheumatoid Arthritis Repeated after an Interval of One YearScandinavian Journal of Rheumatology, 1987
- Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.Annals of the Rheumatic Diseases, 1985
- Prognostic value of early features in rheumatoid disease.BMJ, 1976